The STEP 1 clinical trial demonstrated average weight loss of approximately 15% of body weight over 68 weeks with semaglutide 2.4mg, but these results were achieved in conjunction with dietary counselling and a 500 kcal per day calorie deficit, as highlighted in NICE TA875
The bottom line Ultimately, GLP-1 agonists are possible game changers in the field of medical weight management
So it turns out that you can go around the body and there are all of these specific GLP-1 receptor population, that you can see how they tie into the pharmacology
This formulation is preservative free
However, most compounding pharmacies specify a 28-day or 60-day expiration after first puncture, so you may need to discard the vial before all 12 doses are used
(PubMed) Prasad PD, Wang H, Huang W, et al